Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
Open accessThe DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The cardiovascular system ensures the delivery of oxygen and nutrients to all cells, tissues, and organs. Under extended exposure to reduced oxygen levels, cells are able to survive through the transcriptional activation of a series of genes that participate in angiogenesis, glucose metabolism, and cell proliferation. The oxygen-sensitive transcriptional activator HIF-1 (hypoxia-inducible factor-1) is a key transcriptional mediator of the response to hypoxic conditions. The HIF-1 pathway was found to be a master regulator of angiogenesis. Whether the process is physiological or pathological, HIF-1 seems to participate in vasculature formation by synergistic correlations with other proangiogenic factors such as VEGF (vascular endothelial growth factor), PlGF (placental growth factor), or angiopoietins. Considering the important contributions of HIF-1 in angiogenesis and vasculogenesis, it should be considered a promising target for treating ischaemic diseases or cancer. In this review, we discuss the roles of HIF-1 in both physiological/pathophysiological angiogenesis and potential strategies for clinical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of HIF-α gene structures and DNA binding. (a) HIF-1α and HIF-2α contain the following domains: a nuclear localisation domain (NLS), DNA binding and dimerisation domains (bHLH/PAS), oxygen-dependent degradation domain (ODDD), and cofactor interaction and transcriptional activity domains (N-TAD/C-TAD). HIF-3α lacks a C-TAD domain. NLS: nuclear localisation signal; bHLH: basic helix-loop-helix domain; PAS: Per-ARNT-Sim motif; ODDD: oxygen-dependent degradation domain; N-TAD: N-terminal transactivation domain; C-TAD: C-terminal transactivation domain. (b) Dimerisation of HIF-1α with HIF-1β under hypoxic conditions results in the formation of the HIF-1 transcription factor, which binds to hypoxia response elements (HREs) and activates the transcription of O2-dependent genes (according to [134]).](https://figures.cochat.ai/paper-figures/7f1eff6f4e4b425f9d8561e5e5c9be64/hypoxia-inducible-factor-1-in-physiological-and-pathophysiological-angiogenesis-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the normal developmental setting, HIF-1α plays a dominant role throughout vasculogenesis, whereas HIF-2α contributes primarily to vessel remodeling and maturation during the later stages of vasculogenesis (the HIF switch) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Characteristics of tumor vasculature include lack of stabilization by pericytes and smooth muscle cells and a lack of an arterial or venous phenotype that leads to leakage, poor blood flow and perfusion (Figure 3) [25].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727 · cited 2×
“Because the uterine environment is hypoxic it is thereby obvious that hypoxiamay be the primary stimulus of vessel formation [3, 4].”
BackgroundMolecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276 · cited 1×
“growth factors that activate their receptors [5, 6].”
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“Vessel formation occurs via only two basicmechanisms: vasculogenesis and angiogenesis [2].”
BackgroundActivation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Research works printed but not linked: 1
- Folkman J. Holland J. F. Bast R. C. Jr. Morton D. L. Frei E. III Kufe D. W. Weichselbaum R. R. Tumour angiogenesis Cancer Medicine 1997 Baltimore, Md, USA Williams & Wilkins 181 204
Cited by
Items 401–500 of 650
Zhao, C., Miao, D., Tan, D., Shi, J., Lv, Q., Xiong, Z., & Zhang, X. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2911390 · Cited by 6
Makyeyeva, L., Belenichev, I. F., Aliyeva, O. G., Frolov, O., Petakh, P., & Kamyshnyi, O. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656214 · Cited by 6
Liu, C., Liu, G., Zuo, X., Qu, D., Sun, Y., Liu, L., Zhao, X., Li, J., & Cai, L. (2024) · BMC Neurology · doi:10.1186/s12883-024-03717-w · Cited by 6
Liu, Q., Liu, H., Ye, L.-Q., Li, T., Chen, Z.-M., Wang, Y., Peng, Z., & Wan, L. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s470094 · Cited by 7
“66,77,78 Furthermore, we observed that the PI3K-AKT pathway, which is a crucial regulator of angiogenesis and inflammation, was also enriched, underscoring the potential of VEGFA as an upstream factor of this pathway.”
BackgroundThe Research Progress: Cuproptosis and Copper Metabolism in Regulating Cardiovascular Diseases
Yanjuan, L., Shuangyou, D., Ying, W., Chen, X., Chen, Y., Yu, Z., Zhang, S., Lingli, C., & Li, J. (2024) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001653 · Cited by 6
Macrophage induces angiogenesis via HIF signaling in denervated muscle following nerve injury
Yamada, Y., Surboyo, M. D. C., Rosenkranz, A. L., Ujita, T., Fang, M., Fadhlallah, P. M. E., Maekawa, T., Sato, Y., Yoshiba, N., & Maeda, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-07536-y · Cited by 6
Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection
Li, L., Zeng, Z., Yagublu, V., Rahbari, N. N., Reißfelder, C., & Keese, M. A. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13060990 · Cited by 6
“HIFs were also reported as mediators of the hypoxic response which regulate more than 2% of genes in vascular endothelial cells either directly or indirectly [33].”
BackgroundNestin identifies a subpopulation of rat ventricular fibroblasts and participates in cell migration
Hertig, V., Villeneuve, L. R., & Calderone, A. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00161.2023 · Cited by 6
Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals
Letafati, A., Mozhgani, S., Marjani, A., Amiri, A., Siami, Z., Mohammaditabar, M., Molaverdi, G., & Hedayatyaghoobi, M. (2023) · Medical Oncology · doi:10.1007/s12032-023-02177-5 · Cited by 7
Vogt, S. K., Ramzan, R., Cybulski, P., Rhiel, A., Weber, P., Ruppert, V., Irqsusi, M., Rohrbach, S., Niemann, B., Mirow, N., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14607 · Cited by 6
“54”
Automated production of nerve repair constructs containing endothelial cell tube-like structures
Smith, P. O., Huang, G., Devries, K., Nazhat, S. N., & Phillips, J. B. (2024) · Biofabrication · doi:10.1088/1758-5090/ad8efd · Cited by 6
“The downregulation of genes linked to endothelial cell angiogenic proliferation, ENG, HIF1 α , VEGFa and VEGFR2 (Fonsatti et al 2003, Zimna and Kurpisz 2015, Abhinand et al 2016), could imply the remodelling was linked to a reduction of angiogenesis over time, which is consistent with the changes…”
Luo, M., Mo, D.-C., Li, J., Liu, L., Li, X., Lin, J., Liang, J., Ye, F., Lin, X., Wang, P., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04763-2 · Cited by 6
“HIF-1α participates in the formation of the vascular system through synergistic correlation with other vascular factors including VEGF, placental growth factor (PLGF), and angiopoietin [23].”
Wu, S., Jiang, F., Wu, H., Wang, Y., Xu, R., Cao, J., Lu, Q., Zhu, X., Zhong, Z., & Zhao, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8409 · Cited by 6
“Dimerization of HIF‑1 α and HIF‑1 β in hypoxic conditions results in the formation of the HIF‑1 transcription factor, which translocates to the nucleus to bind to hypoxia response elements and activate the transcription of oxygen‑dependent genes (31).”
Effect of ghrelin on hypoxia-related cardiac angiogenesis: involvement of miR-210 signalling pathway
Mirzaei, F., Karimi‐Sales, E., Alihemmati, A., & Alipour, M. R. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1675712 · Cited by 6
“Since HIF-1 is the main regulator of hypoxia-induced angiogenesis (Zimna and Kurpisz 2015) and VEGF is the best-studied HIF-1-regulated angiogenic factor as well as a strong angiogenic stimulator (Forsythe et al.”
BackgroundInfluentialCalle, X., Jiménez-Gallegos, D., Muñoz‐Córdova, F., Sánchez, P., & Lavandero, S. (2019) · Revista chilena de cardiología · doi:10.4067/s0718-85602019000300225 · Cited by 6
Teng, B., Xie, C., Zhao, Y., Zeng, Q., Zhan, F., Feng, Y., & Wang, Z. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.926508 · Cited by 6
“The hypoxic microenvironment results in the activation of hypoxia-inducible factor (HIF)-1, which can regulate the expression of several angiogenesis-related genes, including vascular endothelial growth factor (VEGF) and its receptors FLT-1, FLK-1, ANG-1, ANG-2, and TIE-2, thus affecting the state of AAA (Zimna and Ku…”
BackgroundLi, X., Ma, W., Liu, H., Wang, D., Su, L., & Yang, X. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002343 · Cited by 6
Li, A. H., Park, S. Y., Li, P., Zhou, C., Kluz, T. S., Li, J., Costa, M., & Sun, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031783 · Cited by 7
“HIF1 α is a key regulator in the adaptation of cancer cells to hypoxic conditions commonly found in tumor microenvironments and plays important roles in metabolic reprogramming, cell migration, stem cell renewal, and angiogenesis [54–56].”
BackgroundLi, L., Liu, N., Dai, X., Yan, H., Zhang, L., Xing, L., Wáng, Y., & Wang, Y. (2016) · RSC Advances · doi:10.1039/c6ra19212b · Cited by 6
Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders
Saadh, M. J., Muhammad, F. A., Albadr, R. J., Sanghvi, G. V., Ballal, S., Pathak, P. K., Bareja, L., Aminov, Z., Taher, W. M., Alwan, M., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02649-6 · Cited by 5
“In addition, they identified HIF-1α as the precise target of miR-19a-3p, a regulator of numerous essential genes involved in the angiogenesis process [177].”
Ganapathy, A., Chen, Y., Bakthavachalam, V., & George, A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1630129 · Cited by 5
Akl, M. M., & Ahmed, A. K. K. (2026) · Medical Gas Research · doi:10.4103/mgr.medgasres-d-25-00137 · Cited by 5
Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer
Wang, R., Gao, C., Meng, Y., Song, J., Feng, Z., Wang, R., Pan, H., Liu, H., Li, W., & Fan, X. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04516-z · Cited by 5
“HIF (hypoxia-inducible factor) [47], a transcription factor crucial for tumor angiogenesis, cell survival, proliferation, apoptosis, metastasis, infiltration, and metabolism [48], plays a pivotal role in promoting lung cancer cell proliferation under conditions of chronic intermittent hypoxia [49].”
BackgroundYang, S., Cui, Y., Ma, R., Yu, S., Zhang, H., Zhao, P., & He, J. (2025) · Biomolecules · doi:10.3390/biom15020256 · Cited by 6
Gara, E., Ong, S., Winkler, J., Zlabinger, K., Lukovic, D., Merkely, B. P., Emmert, M. Y., Wolint, P., Hoerstrup, S. P., Gyöngyösi, M., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.767985 · Cited by 5
“HIF-1α is well recognized as a master regulator of angiogenesis, (Zimna and Kurpisz 2015), and our results show a profound increase of a number of proteins involved in angiogenesis upon pMSC transplantation.”
ResultGaletaki, D. M., Cai, C. L., Bhatia, K., Chin, V. L., Aranda, J. V., & Beharry, K. D. A. (2022) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2022.101513 · Cited by 5
Dariushnejad, H., Roshanravan, N., Pirzeh, L., Cheraghi, M., & Ghorbanzadeh, V. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01198-1 · Cited by 5
Hypoxia in skeletal muscles: from physiology to gene expression
(2016) · Musculoskeletal Regeneration · doi:10.14800/mr.1193 · Cited by 6
“A number of studies have indicated that hypoxia is a trigger of angiogenesis [28, 61-63] .”
BackgroundNie, S.-C., Yang, K., Luan, N.-N., Lian, X.-L., Dai, X.-H., Liang, S.-X., & Yan, Y.-B. (2022) · Medical Science Monitor · doi:10.12659/msm.934511 · Cited by 5
“The cells were stained with antibody to VEGF (green), and CD31 (red).”
BackgroundInfluentialFuchs, B., Birt, A., Moellhoff, N., Kuhlmann, C., Giunta, R. E., & Wiggenhauser, P. S. (2023) · Medicina · doi:10.3390/medicina59040706 · Cited by 6
“Additionally, HIF1a synergistically correlates with other proangiogenic factors such as placental growth factor (PlGF), platelet-derived growth factor (PDGF), angiopoietins 1 and 2 (ANGPT1 and ANGPT2), and metalloproteinases (MMPs), thereby upregulating the major proangiogenic vascular endothelial growth factor (VEGF)…”
BackgroundImportance of vascularity and blood flow in the reproductive system of female birds: a review
Machura, M. H., & Hrabia, A. (2024) · ANIMAL SCIENCE AND GENETICS · doi:10.5604/01.3001.0054.8627 · Cited by 4
EGLN1 inhibition reverses angiogenesis impairment in hyperglycemia by activating autophagy
Hu, F., Li, Z., Li, Y., Zhi, Y., Tang, T. F., Wang, P., & Xue, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-19745-6 · Cited by 4
“Previous studies have found that EGLN1 regulates hypoxia-inducible factor (HIF)’s degradation through hydroxylation modification 15 and EGLN1/HIF can regulate angiogenesis-related genes such as VEGF, Notch ligand and endothelial nitric oxide synthase (eNOS) 41,42 .”
Silent Guardians Gone Rogue: The Role of PIWI and piRNA in Malignant Transformation
Lalruatfela, A., Biswal, P., Behera, S. K., Biswal, S., Dash, J. J., Behera, D. K., & Mallick, B. (2025) · IUBMB Life · doi:10.1002/iub.70077 · Cited by 4
Silva, K., Valero, P., Espinoza, F., Rivas, J. C., Sauceda-Acosta, D., & Sobrevía, L. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_803 · Cited by 5
Emerging Therapeutic Targets in Rheumatoid Arthritis: Focusing on HIF-1α, Nrf2, STATs, and RORγt
Prajapati, P. S., Singh, P. K., & Doshi, G. (2025) · Current Drug Targets · doi:10.2174/0113894501372670250408074908 · Cited by 5
Elmetwally, M. A., Adlan, F., Hendam, B. M., Samy, A., Rezk, S., Lashen, S., Mohram, H., Shalapy, S., Fahmy, R. A., Montgomery, A. J., et al. (2025) · Animal Reproduction · doi:10.1590/1984-3143-ar2024-0125 · Cited by 5
“HIF-1 was discovered to be a master regulator of angiogenesis (Zimna and Kurpisz, 2015).”
The inhibition of protein translation promotes tumor angiogenic switch
Luo, H. B., Shen, Y., Liao, W., Li, Q., Wu, N., Zhong, J., Xiao, C., Gan, J., Yang, Y., Dong, E., et al. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00081-4 · Cited by 4
Kunder, S., Chatterjee, A., Manna, S., Mahimkar, M. B., Patil, A. J., Rangarajan, V., Budrukkar, A. N., Laskar, S. G., Agarwal, J. P., & Gupta, T. (2021) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_91_20 · Cited by 4
“microenvironment to regulate complex biological processes such as metabolism,[19] angiogenesis and invasion,[20] metastasis,[21] and suppression of antitumor immunity[22]”
BackgroundMolecular Mechanisms in the Pathogenesis of Retinopathy of Prematurity (ROP)
Kaur, T., Patnaik, S., Kumar, S., & Kaur, I. (2022) · Springer eBooks · doi:10.1007/978-981-16-4247-0_9 · Cited by 4
Effects of Hypoxia-Inducible Factor 1 (HIF-1) Signaling Pathway on Acute Ischemic Stroke
Li, G., Liang, T., & Wu, H. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/1860925 · Cited by 4
“In ischemic brain tissue, both are expressed on neurons with the same expression phase [7].”
BackgroundRetractedPerioperative Intermittent Fasting Protects Ischemic Musculocutaneous Flap Tissue from Necrosis
Weinzierl, A., Harder, Y., Menger, M. D., & Laschke, M. W. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000010085 · Cited by 4
Chen, H., Hao, P.-H., Zhang, F., & Zhang, T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114346 · Cited by 5
Applications of nanotechnology in the treatment of pulmonary diseases
Dey, R. K., Jana, B., & Dastidar, D. G. (2023) · Vessel Plus · doi:10.20517/2574-1209.2023.06 · Cited by 7
Sun, J., Shen, W., An, W., Li, Q., Qiu, S., & Jiang, S. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/8147258 · Cited by 4
“As a nuclear transcription factor, HIF-α was always highly expressed in anoxic environment, which was an effective marker for hypoxia [27].”
BackgroundBrouwers, A., Dingjan, P., Dujardin, B. C. G., van Zoelen, E. J. J., Lips, P. T. A. M., & Gooren, L. J. (2018) · Clinical Rheumatology · doi:10.1007/s10067-018-4044-z · Cited by 4
“These findings suggest activation of the HIF-1 pathway, resulting in angiogenesis, in which VEGF and PDGF play a role [13].”
BackgroundInfluentialNew insights into reductive stress responses and its clinical relation in cancer
Ray, S. K., & Mukherjee, S. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102736 · Cited by 3
Role of genetic polymorphisms in residual ridge resorption of mandible – A scoping review
Venkatesh, S. B., & Shetty, S. S. (2025) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2025.02.002 · Cited by 3
“In hypoxic situations, HIF-1 α expression persists until tissues achieve a balance of oxygen supply and consumption [21].”
Li, X., Yew, Y. W., Lim, J. S. Y., Attia, A. B. E., Bi, R., Moothanchery, M., Thng, S. T. G., Olivo, M., & Dinish, U. S. (2025) · Biomedical Optics Express · doi:10.1364/boe.559491 · Cited by 3
“Similarly, obesity causes hypervascularization possibly because of increased hypoxia inducible factor 1-alpha (HIF-1 α ), a key regulator in angiogenesis [42].”
Role of Succinate Dehydrogenase in Cellular Respiration
Viswalingam, V., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_3 · Cited by 3
Atta, A. M., Nafie, M. S., Ali, H. A., Saleh, H. K., Roshdy, M. A., Mahmoud, M. M., Eid, E. A., Ahmed, M. A., Gerges, M. S., Ghoneim, A. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-29322-6 · Cited by 3
Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma
Harbi, E., Yozgat, Y., Bozbey, H. U., Taştekin, D., Oncul, O., Hosseiny, S., Yahya, D., Yildiz, O., Erdoğan, M., Slocum, A. K., et al. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02275-5 · Cited by 4
“Under hypoxic conditions, the activation of HIF-1α and HIF-1β increases VEGF synthesis, and this ligand binds to VEGFR2, inducing several cellular mechanisms [27, 28].”
Kanthireegala, S. K., Lekkala, V. V. V., Lebaka, V. R., Reddy, M. C., Lomada, D., & Mandal, T. K. (2026) · Biomaterials Science · doi:10.1039/d5bm01787d · Cited by 4
Vārtiņa, E., Pilmane, M., & Lacis, R. (2021) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2021-0028 · Cited by 3
Дергилев, К. В., Цоколаева, З. И., Vasilets, Y. D., Beloglazova, I. B., & Parfenova, E. V. (2021) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2021-10-3-34-43 · Cited by 3
Wilhelmi, P., Haake, V., Zickgraf, F. M., Giri, V., Ternes, P., Driemert, P., Nöth, J., Scholz, S., Barenys, M., Flick, B., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03655-5 · Cited by 3
“Yet, apart from VEGFR2 signaling, many other molecular modulators, such as HIF-1 (hypoxia-inducible factor 1), FGF (fibroblast growth factor) or Notch signaling, steer angiogenesis (Andersson et al. 2011; Presta et al. 2005; Zimna and Kurpisz 2015).”
BackgroundNurtanio, T., Nabila, B. Z., Fachiroh, J., Nuraini, N., & Purnomosari, D. (2024) · Placenta · doi:10.1016/j.placenta.2024.07.006 · Cited by 3
Zeng, X., Xie, Y., Guo, T., Gao, Z., Wang, K., Yang, Q., & Li, M. (2024) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000004122 · Cited by 3
Hypoxia, Angiogenesis and Atherogenesis
Heikal, L., & Ferns, G. A. (2017) · InTech eBooks · doi:10.5772/66714 · Cited by 3
“the ability to shift its dependence from VEGF to other proangiogenic pathways, for example, through the recruitment of myeloid cells and the upregulation of alternative vascular growth factors (PlGF and FGF) [1].”
BackgroundInfluentialTumor Angiogenesis and Modulators
Xu, K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.95139 · Cited by 3
Zeng, P., Liu, W., Yang, X., Zhang, S., Du, S., Fan, Y., Zhao, L., & Wang, A. (2022) · Disease Markers · doi:10.1155/2022/6153459 · Cited by 3
RetractedChen, K., Zhang, M., Fan, L., & Wang, Z. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8823231 · Cited by 4
“+e HIF-1 pathway is a major regulator of angiogenesis, an adaptive response to tissue hypoxia [44, 45].”
BackgroundCytochrome-Derived EETs, VEGF-A, and NOX4: Piecing the Puzzle Together
Jandeleit-Dahm, K. A. M., & Meister, J. (2023) · Diabetes · doi:10.2337/dbi23-0006 · Cited by 3
Prasetyorini, N. (2024) · F1000Research · doi:10.12688/f1000research.73820.3 · Cited by 4
Effects of exercise training on prostate cancer: Current evidence and potential molecular mechanisms
Webber, M., Li, M., Cai, C., & Zou, K. (2024) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2024.08.003 · Cited by 3
The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm
Wei, P., Li, K., Li, M., Liu, H., Xia, C., Chen, Y., Zhao, S., & Li, Y.-K. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1462032 · Cited by 3
Huang, B., Li, F., Su, S., Chen, C., Chang, K., Yang, M., Chen, M., Chiang, H. K., Chan, Y., & Lee, Y. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70324 · Cited by 2
Orǎșanu, C. I., Aşchie, M., Deacu, M., Boşoteanu, M., Vameşu, S., Enciu, M., Cozaru, G. C., Mitroi, A. F., Ghitoi, S. A., Cretu, A. M., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15040438 · Cited by 2
TCF12 enhances angiogenesis and affects sorafenib response in liver cancer via HIF-1α interaction
Chen, Y., Wang, X., Chen, J., Dai, M., Zhang, X., Yin, J., & He, X. S. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.12022 · Cited by 2
“Additionally, HIF-1 α can interact with the histone acetyltransferase p300 to enhance the expression of downstream genes [9].”
Sun, Y., Chen, L., Xiao, L., Wang, X., & Hallajzadeh, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1560305 · Cited by 2
“HIF-1 α is crucial for initiating angiogenesis in response to low oxygen levels, enabling the body to adapt to changes in oxygen availability and maintain tissue viability (Zimna and Kurpisz, 2015).”
Zhao, K., Jiang, Y., Huang, W., Mao, Y., Chen, Y., Li, P., & Yang, C. (2025) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500154 · Cited by 2
“HIF-1, the oxygen-sensitive transcriptional activator, can orchestrate the process of angiogenesis by indirect cascade effects or direct binding to hypoxia-response element (HRE) sites in the promoters of HIF-1 target encoding genes like vegf (Zimna and Kurpisz, 2015).”
Dear, T. B., Chang, E. I., Al‐Juboori, S. I., Stremming, J., Wesolowski, S. R., Jonker, S. S., Rozance, P. J., Dobrinskikh, E., & Brown, L. D. (2025) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00044.2025 · Cited by 2
Dayel, A. F. B., Alhejji, R. M., Alonazi, A. S., & Al-Rasheed, N. M. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12110438 · Cited by 2
“Cardiac angiogenesis, the process by which new blood vessels develop from pre-existing ones, is an essential compensatory mechanism in hypoxia cardiomyocyte injuries [5].”
HIF-1α/BNIP3L–mediated mitophagy is involved in T-2 toxin–induced myocardial injury
Li, Q., Wang, M., Zuo, J., Dong, Z., Sha, T., Luo, K., Zhang, H., Dou, Y., Zhou, G., Ba, Y., et al. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111844 · Cited by 2
Hu, Z., Huang, J., Chen, S., Xie, J., Jia, S., Zhao, C., Lu, W., Huang, J., Li, L., Li, S., et al. (2026) · Burns · doi:10.1016/j.burns.2026.107873 · Cited by 2
Srb, N., Milostić-Srb, A., Sarić, L., Holik, D., Šapina, M., Fureš, R., Talapko, J., Škrlec, I., Katalinić, D., & Kovačić, B. (2026) · Medical Sciences · doi:10.3390/medsci14010061 · Cited by 2
“In physiological and pathological processes, hypoxia is mediated by the hypoxia-inducible factor (HIF) since oxygen is necessary for tissue functioning [15,16].”
Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss
Pramoda, G., Shivhare, K., Gupta, P. K., Sahebkar, A., Kesharwani, P., & Shukla, R. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71155 · Cited by 2
Functional foods from the tropics to relieve chronic normobaric hypoxia
Ghattamaneni, N. K. R., & Brown, L. (2020) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103599 · Cited by 3
Ali, A. M. E. A., Ahmed, A. S., El-Yasergy, D. F., Abousarie, M. A., Elsayed, R. M., Mohammed, Y. E., & Mohammed, R. A. (2021) · PubMed Central · doi:10.22038/ijbms.2021.55861.12491 · Cited by 2
Mechanisms of Plasticity Remodeling and Recovery
Zheng, Z., Chen, J., & Chopp, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00011-9 · Cited by 3
Role of succinate dehydrogenase in hepatocellular carcinoma
Srivani, G., Imran, M., Merchant, N., Mandala, J. P., & Nagaraju, G. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98806-3.00014-3 · Cited by 2
Exploration of the Growing Therapeutic Potentials of Quercetin in Ovarian Cancer Management
Gupta, D., Gadi, V., Kaur, G., Gupta, M., Kumar, A., & Tuli, H. S. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00343-x · Cited by 2
“4) [26, 77].”
Петровна, Ч. С., Urazova, O. I., Shipulin, V. M., Суходоло, И. В., Stelmashenko, A. I., Анатольевна, Д. О., Andreev, S. L., Demin, M. S., & Георгиевна, Ч. Е. (2024) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2023-8.6.7 · Cited by 2
Mechanisms of chemotherapy resistance in cervical cancer
Marima, R. M., Mosoane, B., Mtshali, N. Z., Basera, A., Kgatle, M., Grech, G., & Dlamini, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28985-9.00012-4 · Cited by 2
CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
Xie, D., Chen, Y., Hu, S., Huang, L., & Huang, J. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.278 · Cited by 3
Pan, L., He, X., Xu, R. C., Bhattarai, U., Niu, Z., do Carmo, J. M., Sun, Y., Zeng, H., Clemmer, J. S., Chen, J., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01108-0 · Cited by 2
“First, PHD2 deficiency can enhance angiogenesis, vessel remodeling/generation, and collateral vessel formation by increasing HIF1 stability in skeletal and cardiac muscles partially through modulating HIF1, VEGF, and NO signaling pathways [28, 29].”
BackgroundLow‐dose estrogen release from silastic capsule enhanced flap wound healing in an animal model
Wang, Y., Chen, C., Chou, K., Huang, S., & Ou, K. (2024) · International Wound Journal · doi:10.1111/iwj.70083 · Cited by 2
“36 As an angiogenic biomarker, CD31 detects new capillaries or vessels.”
BackgroundStanić, R., Vukojević, K., Filipović, N., Benzon, B., Ogorevc, M., Kunac, N., Čanović, S., Kovačević, P., Šimunović, M. P., & Konjevoda, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312618 · Cited by 2
“Considering that the conjunctival stroma and episclera are highly vascularized tissues, the immunoexpression of HIFa in these regions may indicate an adaptive response to maintain cellular function and promote angiogenesis under hypoxic conditions [27,28].”
Станиславович, Д. С., Primak, A. L., Basalova, N. A., Kalinina, N., Monakova, A., Дмитриевич, Б. К., Velichko, A., Illarionova, M. E., Grigorieva, O., Akopyan, Z. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146697 · Cited by 4
“VHL (Von Hippel–Lindau) is a negative master regulator of HIF proteins, a family of transcription factors [20,21], inducing cell metabolism adaptation and expression of a wide range of pro-angiogenic molecules (VEGF, erythropoietin, angiopoietins 1/2, PlGF, HGF, etc.) in response to hypoxia [22,23].”
Bellissimo, C. J., Yeo, E., Ribeiro, T. A., Jazwiec, P. A., Ellewela, C. N., Bains, J., Lewis, A. E., Kennedy, K. M., Ashkar, A. A., Beristain, A. G., et al. (2025) · Acta Physiologica · doi:10.1111/apha.70130 · Cited by 3
“Several of the factors elevated within the decidua of HFHS dams have roles in both the normal progression of spiral artery remodeling [3, 13, 85, 90–92], as well as endothelial activation/inflammation [60, 93–95], and are regulated by tissue oxygenation [96, 97].”
Embryology and Classification of Congenital Upper Limb Anomalies
Garrido-Allepuz, C., Tonkin, M. A., & Oberg, K. C. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7504-1_1 · Cited by 2
Hapsari, A., Setyaningrum, D. A. W., Wardhani, R. P., Alfina, A., Ginting, R. B., & Dzakiy, W. A. (2017) · International Integrative Conference on Health, Life and Social Sciences (ICHLaS) · doi:10.2991/ichlas-17.2017.2 · Cited by 3
Чумак, З. В., Шаповал, М. В., Nadvorna, О. М., & Zhovtenko, O. V. (2021) · Актуальні питання педіатрії акушерства та гінекології · doi:10.11603/24116-4944.2020.2.11863 · Cited by 3
The Role of N6-Methyladenosine Modification in Microvascular Dysfunction
Zhang, Y.-R., Ji, J.-D., Wang, J., Wang, Y., Zhu, H.-J., Sun, R.-X., Liu, Q., & Chen, X. (2022) · Cells · doi:10.3390/cells11203193 · Cited by 3
“The following steps are involved in neovascularization: (1) recognition of physiological or pathological signals, such as hypoxia, inflammation, and metabolic dysregulation; (2) secretion of proteases, pro-angiogenic factors and cytokines, and their bindings to corresponding receptors; (3) metabolic changes of vascula…”
BackgroundAfşar, B., & Afşar, R. E. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00497-x · Cited by 2
“In endothelial cells, HIF-1α directly induces vascular endothelial growth factor (VEGF) mRNA and protein expressions to facilitate angiogenesis [24].”
BackgroundEvaluation of Borax Pentahydrate as a Novel Antiangiogenic AgentPreprint
YILMAZ, H., Özbek, E. N., İşel, E., BÜTÜNER, B. D., Yetik-Anacak, G., Koparal, A. T., & Ulus, G. (2023) · Research Square · doi:10.21203/rs.3.rs-3267555/v1 · Cited by 2
Oxenrider, A., Bui, T., Lester, J., Seth, G., Brokemond, A. J., Thounaojam, M. C., Martin, P. M., & Jadeja, R. N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.03.597234 · Cited by 2
“Hypoxia-inducible factor-1 (HIF-1α) is a master transcriptional regulator of cellular responses to hypoxia and plays a key role in retinal neovascularization [40-42].”
BackgroundHIF-1α and VEGF polymorphisms and systemic lupus erythematosus susceptibility
Saravani, M., Sandoughi, M., Heidary, Z., Ebrahimi, G., Mirzamohammadi, S., Haddadi, M., & Nematollahi, M. H. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100982 · Cited by 2
Vascularization of 3D Engineered Tissues
Ju, Y. M., Atala, A., & Yoo, J. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-05336-9_22 · Cited by 1
Coutinho, D. C. O., Joviano‐Santos, J. V., Santos‐Miranda, A., Martins‐Júnior, P. A., Silva, A. D., Santos, R. A. S., & Ferreira, A. J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.014 · Cited by 1
Hypoxia-Mediated Upregulation of Semaphorin 3A during Pulp Revascularization
Wang, W., Zhang, H., & Liu, Y. (2022) · Open Journal of Stomatology · doi:10.4236/ojst.2022.127019 · Cited by 1
Metadata
- Authors
- Zimna, A., & Kurpisz, M.
- Affiliations
- Institute of Human Genetics (PL)
- Corresponding author
- Kurpisz, Maciej
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4471260
- OpenAlex
- W1597158509
- Cited by
- 604
- References
- 138
- Citations by year
- 2026: 40 · 2025: 66 · 2024: 88 · 2023: 78 · 2022: 67 · 2021: 79 · 2020: 64 · 2019: 45 · 2018: 22 · 2017: 28 · 2016: 23 · 2015: 3
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Science Centre, Poland (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- National Centre for Research and Development (2012/07/N/NZ3/01687, 2014/13/B/NZ3/04646, STRATEGMED1/233624/5/NCBR/2014)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- HIF-1, angiogenesis, hypoxia, vascular endothelial growth factor, placental growth factor, angiopoietins, vasculogenesis, ischemic diseases, cancer, oxygen sensing, transcriptional regulation
- MeSH terms
- Placenta Growth Factor, Hypoxia, Humans, Neovascularization, Pathologic, Pregnancy Proteins, Transcriptional Activation, Cell Hypoxia, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.